Does TREPROSTINIL Cause Epistaxis? 1,726 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,726 reports of Epistaxis have been filed in association with TREPROSTINIL (TYVASO). This represents 1.9% of all adverse event reports for TREPROSTINIL.
1,726
Reports of Epistaxis with TREPROSTINIL
1.9%
of all TREPROSTINIL reports
96
Deaths
636
Hospitalizations
How Dangerous Is Epistaxis From TREPROSTINIL?
Of the 1,726 reports, 96 (5.6%) resulted in death, 636 (36.8%) required hospitalization, and 20 (1.2%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 1,726 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
METHOTREXATE (1,108)
Which TREPROSTINIL Alternatives Have Lower Epistaxis Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE